BridgeBio Oncology Therapeutics (BBOT) via Helix II (HLXB) deck
BridgeBio is a clinical-stage biopharmaceutical company developing next-generation small molecule therapies for RAS and PI3Kα-driven cancers.
BridgeBio is a clinical-stage biopharmaceutical company developing next-generation small molecule therapies for RAS and PI3Kα-driven cancers.
%20via%20Helix%20II%20(HLXB)%20deck){kind=link}